SEDORRHOIDE CRISE HEMORROIDAIRE, suppository 8 suppositories
Active ingredients: Benzocaine, Dodeclonium bromide, ESCULOSIDE SESQUIHYDRATÉ, Enoxolone
Commercialized according to BDPM
Suppository8 suppositoriesrectale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SEDORRHOIDE CRISE HEMORROIDAIRE, suppositoire
- Pharmaceutical form
- suppositoire
- Route of administration
- rectale
- Presentation description
- plaquette(s) PVC polyéthylène de 8 suppositoire(s)
- Marketing authorisation holder
- COOPER (ABRÉGÉ DE COOPERATION PHARMACEUTIQUE FRANCAISE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Mar 2007
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66426495CIP73762609CIP133400937626095Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BENZOCAÏNEsuppositoire | 50,0 mg · un suppositoire | SA |
| DODÉCLONIUM (BROMURE DE)suppositoire | 1,3 mg · un suppositoire | SA |
| ÉNOXOLONEsuppositoire | 23,0 mg · un suppositoire | SA |
| ESCULOSIDE SESQUIHYDRATÉsuppositoire | 6,0 mg · un suppositoire | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.